Clinical trial
Utility of the AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral Ventilation Assessed by the Chartis System
NCT01460108 is registered in ClinicalTrials.gov with LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Utility of the AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral Ventilation Assessed by the Chartis System
- Lead sponsor
- LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- April 30, 2011
- Completion date
- June 30, 2013
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
copd, lung diseases, pulmonary emphysema